DeepMed Research

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Impact of Topical Tranexamic Acid in Breast Reconstruction

Phase 4

Terminated

Conditions: Breast Cancer

Interventions: Drug: Tranexamic Acid
Other: Saline

First Posted Date: 2023-04-10

Last Posted Date: 2025-02-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 23

Registration Number: NCT05807074

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Investigating the Use of Intravenous Tranexamic Acid in Gender Affirming Mastectomy

Phase 2

Recruiting

Conditions: Postoperative Seroma
Postoperative Hematoma

Interventions: Drug: Intravenous TXA

First Posted Date: 2023-04-03

Last Posted Date: 2023-11-18

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 150

Registration Number: NCT05794321

Locations: 🇺🇸
UCSF Department of Plastic & Reconstructive Surgery, San Francisco, California, United States

Youth Ending the HIV Epidemic

Not Applicable

Completed

Conditions: HIV/AIDS
Mobile Health
Young Adults

Interventions: Other: aDOT-CEI

First Posted Date: 2023-03-29

Last Posted Date: 2024-08-26

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 28

Registration Number: NCT05789875

Locations: 🇺🇸
UCSF Center for AIDS Prevention Studies, San Francisco, California, United States

Behavioral Health Evaluation and Intervention Program for Patients Undergoing Craniotomy

Not Applicable

Not yet recruiting

Conditions: Brain Tumor

Interventions: Behavioral: Counseling Sessions
Behavioral: Quality of Life Questionnaires

First Posted Date: 2023-03-29

Last Posted Date: 2025-01-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT05789862

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Australian University of California San Francisco (UCSF) Concussion in Athletes (AUSSIE-2)

Completed

Conditions: Concussion, Mild

Interventions: Device: Headpulse measurements

First Posted Date: 2023-03-16

Last Posted Date: 2023-03-16

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 68

Registration Number: NCT05771051

Locations: 🇺🇸
UCSF, San Francisco, California, United States

Australian UCSF Concussion in Athletes

Completed

Conditions: Concussion, Mild

Interventions: Device: Headpulse measurements

First Posted Date: 2023-03-15

Last Posted Date: 2023-03-17

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 34

Registration Number: NCT05769296

Locations: 🇺🇸
UCSF, San Francisco, California, United States

SEARCH SAPPHIRE Phase B

Not Applicable

Recruiting

Conditions: HIV

Interventions: Behavioral: Community-enhanced reach activities
Behavioral: Standard of Care
Behavioral: Person-centered care delivery
Other: Data system enhancement to improve reach and person-centered delivery

First Posted Date: 2023-03-14

Last Posted Date: 2025-01-31

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80000

Registration Number: NCT05768763

Locations: 🇺🇬
Infectious Diseases Research Collaboration, Kampala, Uganda
🇰🇪
SEARCH Office / GPRT, Kisumu, Kenya

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

Phase 2

Recruiting

Conditions: Castrate Resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Prostate Cancer
Prostate Carcinoma

Interventions: Drug: Pembrolizumab
Drug: 177Lu-PSMA-617

First Posted Date: 2023-03-13

Last Posted Date: 2025-03-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 48

Registration Number: NCT05766371

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Vitality in Infants Via Azithromycin for Neonates Trial

Phase 4

Not yet recruiting

Conditions: Neonatal Death
Infectious Disease
Nutritional Deficiency

Interventions: Drug: Azithromycin at Baseline
Drug: Azithromycin at Day 21
Other: Placebo at Day 21
Other: Placebo at Baseline

First Posted Date: 2023-03-10

Last Posted Date: 2023-12-04

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 5000

Registration Number: NCT05763693

Locations: 🇧🇫
Centre de Recherche en santé de Nouna, Nouna, Burkina Faso

Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology

Recruiting

Conditions: Asthma

First Posted Date: 2023-03-07

Last Posted Date: 2025-02-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 80

Registration Number: NCT05757583

Locations: 🇺🇸
UCSF Airway Clinical Research Center, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy